Report Detail

Other Global Continuous Glucose Monitoring Systems Market Insights, Forecast to 2025

  • RnM2398800
  • |
  • 21 May, 2019
  • |
  • Global
  • |
  • 117 Pages
  • |
  • QYResearch
  • |
  • Other

Continuous glucose monitoring systems helps to manage diabetes by providing real time values of the glucose levels and alerts to the patient in the event of hypo or hyperglycemia. This helps reduce the probability of any complications related to diabetes. In addition, CGMS offers varied benefits over other glucose monitors in monitoring the blood glucose levels of ICU patients. The major factors that drive the growth include surge in geriatric population and high prevalence of population suffering from diabetes. However, lack of adequate reimbursement for devices is the key barrier to the adoption of the devices.
The market is categorized based on component, end user, and region. The CGMS components market includes durable components such as transmitters & receivers and integrated insulin pumps; and disposable components such as sensors. The segment for sensors occupies a dominant share in the CGMS market due to recurring sales of CGMS, short scrap life, and bulk purchases. Therefore, it is deployed in diagnostic centers/clinics. Moreover, the adoption of CGMS in hospital ICUs and in-home healthcare settings has increased in the recent years.
The global Continuous Glucose Monitoring Systems market is valued at 2600 million US$ in 2018 and will reach 11920 million US$ by the end of 2025, growing at a CAGR of 24.3% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Continuous Glucose Monitoring Systems market based on company, product type, end user and key regions.

This report studies the global market size of Continuous Glucose Monitoring Systems in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Continuous Glucose Monitoring Systems in these regions.
This research report categorizes the global Continuous Glucose Monitoring Systems market by top players/brands, region, type and end user. This report also studies the global Continuous Glucose Monitoring Systems market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Dexcom
Abbott Laboratories
Medtronic
Johnson & Johnson
Roche
Tandem Diabetes Care, Inc.
Fornia Medical
GlySens Incorporated
Senseonics Holdings

Continuous Glucose Monitoring Systems market size by Type
Sensors
Transmitters & Receivers
Integrated Insulin Pumps
Continuous Glucose Monitoring Systems market size by Applications
Diagnostics/Clinics
ICUs
Home Healthcare

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Continuous Glucose Monitoring Systems market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Continuous Glucose Monitoring Systems market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Continuous Glucose Monitoring Systems companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Continuous Glucose Monitoring Systems submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Continuous Glucose Monitoring Systems are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Continuous Glucose Monitoring Systems market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Study Coverage

    • 1.1 Continuous Glucose Monitoring Systems Product Introduction
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Continuous Glucose Monitoring Systems Market Size Growth Rate by Type
      • 1.4.2 Sensors
      • 1.4.3 Transmitters & Receivers
      • 1.4.4 Integrated Insulin Pumps
    • 1.5 Market by Application
      • 1.5.1 Global Continuous Glucose Monitoring Systems Market Size Growth Rate by Application
      • 1.5.2 Diagnostics/Clinics
      • 1.5.3 ICUs
      • 1.5.4 Home Healthcare
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Continuous Glucose Monitoring Systems Market Size
      • 2.1.1 Global Continuous Glucose Monitoring Systems Revenue 2014-2025
      • 2.1.2 Global Continuous Glucose Monitoring Systems Sales 2014-2025
    • 2.2 Continuous Glucose Monitoring Systems Growth Rate by Regions
      • 2.2.1 Global Continuous Glucose Monitoring Systems Sales by Regions
      • 2.2.2 Global Continuous Glucose Monitoring Systems Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Continuous Glucose Monitoring Systems Sales by Manufacturers
      • 3.1.1 Continuous Glucose Monitoring Systems Sales by Manufacturers
      • 3.1.2 Continuous Glucose Monitoring Systems Sales Market Share by Manufacturers
    • 3.2 Continuous Glucose Monitoring Systems Revenue by Manufacturers
      • 3.2.1 Continuous Glucose Monitoring Systems Revenue by Manufacturers (2014-2019)
      • 3.2.2 Continuous Glucose Monitoring Systems Revenue Share by Manufacturers (2014-2019)
    • 3.3 Continuous Glucose Monitoring Systems Price by Manufacturers
    • 3.4 Continuous Glucose Monitoring Systems Manufacturing Base Distribution, Product Types
      • 3.4.1 Continuous Glucose Monitoring Systems Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Continuous Glucose Monitoring Systems Product Type
      • 3.4.3 Date of International Manufacturers Enter into Continuous Glucose Monitoring Systems Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type

    • 4.1 Global Continuous Glucose Monitoring Systems Sales by Type
    • 4.2 Global Continuous Glucose Monitoring Systems Revenue by Type
    • 4.3 Continuous Glucose Monitoring Systems Price by Type

    5 Breakdown Data by Application

    • 5.1 Overview
    • 5.2 Global Continuous Glucose Monitoring Systems Breakdown Data by Application

    6 North America

    • 6.1 North America Continuous Glucose Monitoring Systems by Country
      • 6.1.1 North America Continuous Glucose Monitoring Systems Sales by Country
      • 6.1.2 North America Continuous Glucose Monitoring Systems Revenue by Country
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Continuous Glucose Monitoring Systems by Type
    • 6.3 North America Continuous Glucose Monitoring Systems by Application

    7 Europe

    • 7.1 Europe Continuous Glucose Monitoring Systems by Country
      • 7.1.1 Europe Continuous Glucose Monitoring Systems Sales by Country
      • 7.1.2 Europe Continuous Glucose Monitoring Systems Revenue by Country
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Continuous Glucose Monitoring Systems by Type
    • 7.3 Europe Continuous Glucose Monitoring Systems by Application

    8 Asia Pacific

    • 8.1 Asia Pacific Continuous Glucose Monitoring Systems by Country
      • 8.1.1 Asia Pacific Continuous Glucose Monitoring Systems Sales by Country
      • 8.1.2 Asia Pacific Continuous Glucose Monitoring Systems Revenue by Country
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Continuous Glucose Monitoring Systems by Type
    • 8.3 Asia Pacific Continuous Glucose Monitoring Systems by Application

    9 Central & South America

    • 9.1 Central & South America Continuous Glucose Monitoring Systems by Country
      • 9.1.1 Central & South America Continuous Glucose Monitoring Systems Sales by Country
      • 9.1.2 Central & South America Continuous Glucose Monitoring Systems Revenue by Country
      • 9.1.3 Brazil
      • 9.1.4 Argentina
    • 9.2 Central & South America Continuous Glucose Monitoring Systems by Type
    • 9.3 Central & South America Continuous Glucose Monitoring Systems by Application

    10 Middle East and Africa

    • 10.1 Middle East and Africa Continuous Glucose Monitoring Systems by Country
      • 10.1.1 Middle East and Africa Continuous Glucose Monitoring Systems Sales by Country
      • 10.1.2 Middle East and Africa Continuous Glucose Monitoring Systems Revenue by Country
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Continuous Glucose Monitoring Systems by Type
    • 10.3 Middle East and Africa Continuous Glucose Monitoring Systems by Application

    11 Company Profiles

    • 11.1 Dexcom
      • 11.1.1 Dexcom Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Dexcom Continuous Glucose Monitoring Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Dexcom Continuous Glucose Monitoring Systems Products Offered
      • 11.1.5 Dexcom Recent Development
    • 11.2 Abbott Laboratories
      • 11.2.1 Abbott Laboratories Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Abbott Laboratories Continuous Glucose Monitoring Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Abbott Laboratories Continuous Glucose Monitoring Systems Products Offered
      • 11.2.5 Abbott Laboratories Recent Development
    • 11.3 Medtronic
      • 11.3.1 Medtronic Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Medtronic Continuous Glucose Monitoring Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Medtronic Continuous Glucose Monitoring Systems Products Offered
      • 11.3.5 Medtronic Recent Development
    • 11.4 Johnson & Johnson
      • 11.4.1 Johnson & Johnson Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Johnson & Johnson Continuous Glucose Monitoring Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Johnson & Johnson Continuous Glucose Monitoring Systems Products Offered
      • 11.4.5 Johnson & Johnson Recent Development
    • 11.5 Roche
      • 11.5.1 Roche Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Roche Continuous Glucose Monitoring Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Roche Continuous Glucose Monitoring Systems Products Offered
      • 11.5.5 Roche Recent Development
    • 11.6 Tandem Diabetes Care, Inc.
      • 11.6.1 Tandem Diabetes Care, Inc. Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Tandem Diabetes Care, Inc. Continuous Glucose Monitoring Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Tandem Diabetes Care, Inc. Continuous Glucose Monitoring Systems Products Offered
      • 11.6.5 Tandem Diabetes Care, Inc. Recent Development
    • 11.7 Fornia Medical
      • 11.7.1 Fornia Medical Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Fornia Medical Continuous Glucose Monitoring Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Fornia Medical Continuous Glucose Monitoring Systems Products Offered
      • 11.7.5 Fornia Medical Recent Development
    • 11.8 GlySens Incorporated
      • 11.8.1 GlySens Incorporated Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 GlySens Incorporated Continuous Glucose Monitoring Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 GlySens Incorporated Continuous Glucose Monitoring Systems Products Offered
      • 11.8.5 GlySens Incorporated Recent Development
    • 11.9 Senseonics Holdings
      • 11.9.1 Senseonics Holdings Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Senseonics Holdings Continuous Glucose Monitoring Systems Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Senseonics Holdings Continuous Glucose Monitoring Systems Products Offered
      • 11.9.5 Senseonics Holdings Recent Development

    12 Future Forecast

    • 12.1 Continuous Glucose Monitoring Systems Market Forecast by Regions
      • 12.1.1 Global Continuous Glucose Monitoring Systems Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Continuous Glucose Monitoring Systems Revenue Forecast by Regions 2019-2025
    • 12.2 Continuous Glucose Monitoring Systems Market Forecast by Type
      • 12.2.1 Global Continuous Glucose Monitoring Systems Sales Forecast by Type 2019-2025
      • 12.2.2 Global Continuous Glucose Monitoring Systems Revenue Forecast by Type 2019-2025
    • 12.3 Continuous Glucose Monitoring Systems Market Forecast by Application
    • 12.4 North America Continuous Glucose Monitoring Systems Forecast
    • 12.5 Europe Continuous Glucose Monitoring Systems Forecast
    • 12.6 Asia Pacific Continuous Glucose Monitoring Systems Forecast
    • 12.7 Central & South America Continuous Glucose Monitoring Systems Forecast
    • 12.8 Middle East and Africa Continuous Glucose Monitoring Systems Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Continuous Glucose Monitoring Systems Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Summary:
      Get latest Market Research Reports on Continuous Glucose Monitoring Systems . Industry analysis & Market Report on Continuous Glucose Monitoring Systems is a syndicated market report, published as Global Continuous Glucose Monitoring Systems Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Continuous Glucose Monitoring Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,900.00
      $7,350.00
      $9,800.00
      3,880.80
      5,821.20
      7,761.60
      4,537.40
      6,806.10
      9,074.80
      741,615.00
      1,112,422.50
      1,483,230.00
      408,660.00
      612,990.00
      817,320.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report